QR-Code

DNA demethylating agents suppress preclinical models of synovial sarcoma

Synovial sarcoma is an aggressive soft-tissue cancer driven by the chimeric SS18::SSX fusion oncoprotein, which disrupts chromatin remodeling by combining two antagonistic transcriptional regulators. SS18 participates in BAF complexes that open chromatin, while the SSX genes are cancer-testis antige...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Nobuhiko Hasegawa, Nezha S. Benabdallah, Kyllie Smith-Fry, Li Li, Sarah McCollum, Jinxiu Li, Caelen A. Jones, Lena Wagner, Vineet Dalal, Viola Golde, Anastasija Pejkovska, Lara Carroll, Malay Haldar, Seth M. Pollack, Scott W. Lowe, Torsten O. Nielsen, Ana Banito, Kevin B. Jones
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Clinical Investigation 2025-07-01
Schriftenreihe:The Journal of Clinical Investigation
Schlagworte:
Genetics
Oncology
Online-Zugang:https://doi.org/10.1172/JCI190855
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge